[go: up one dir, main page]

AU3785799A - Method for treating migraine in mammals - Google Patents

Method for treating migraine in mammals

Info

Publication number
AU3785799A
AU3785799A AU37857/99A AU3785799A AU3785799A AU 3785799 A AU3785799 A AU 3785799A AU 37857/99 A AU37857/99 A AU 37857/99A AU 3785799 A AU3785799 A AU 3785799A AU 3785799 A AU3785799 A AU 3785799A
Authority
AU
Australia
Prior art keywords
mammals
treating migraine
migraine
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37857/99A
Inventor
Alvin J. Glasky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spectrum Pharmaceuticals Inc
Original Assignee
Neotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neotherapeutics Inc filed Critical Neotherapeutics Inc
Publication of AU3785799A publication Critical patent/AU3785799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU37857/99A 1998-05-04 1999-05-04 Method for treating migraine in mammals Abandoned AU3785799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8402198P 1998-05-04 1998-05-04
US60084021 1998-05-04
PCT/US1999/009745 WO1999056550A1 (en) 1998-05-04 1999-05-04 Method for treating migraine in mammals

Publications (1)

Publication Number Publication Date
AU3785799A true AU3785799A (en) 1999-11-23

Family

ID=22182382

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37857/99A Abandoned AU3785799A (en) 1998-05-04 1999-05-04 Method for treating migraine in mammals

Country Status (2)

Country Link
AU (1) AU3785799A (en)
WO (1) WO1999056550A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288069B1 (en) * 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ES2420354T3 (en) 2000-07-07 2013-08-23 Spectrum Pharmaceuticals, Inc. Methods for the treatment of peripheral neuropathy induced by a disease and related conditions
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives

Also Published As

Publication number Publication date
WO1999056550A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
AU1527897A (en) Method for treating the prostate
AU2593900A (en) Composition and method for treating glaucoma
AU1484202A (en) Method for treating films
EP0693459A3 (en) Ionized water, and method and apparatus for manufacturing same
AU7085100A (en) Method for treating otic disorders
AU6263599A (en) Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
EP0823401A3 (en) Method for treating waste water
ZA973707B (en) Method for treating inflammation.
AU3295600A (en) Method for treating polymer surface
AU3401199A (en) Method and composition for treating psoriasis
AU2584597A (en) Method for treating migraine pain
AU2430999A (en) Method for treating various products and installation therefor
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
AU2877499A (en) Multi-pass grinding method
AU4454897A (en) Method for treating molded articles
IL130531A0 (en) Method for treating glaucoma
AU1227800A (en) Methods for treating superficial bladder carcinoma
AU4692899A (en) Method for pressure treating wood
AU4672597A (en) Method for treating urinary reflux
AU7107998A (en) Method for treating schizophrenia
AU3785799A (en) Method for treating migraine in mammals
AU6760298A (en) Method for treating hypertension
AU6688798A (en) Method for treating lumber
AU4920700A (en) Method for treating abnormal cell proliferation in the brain
AU3896597A (en) Method for treating substance abuse

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase